Tissue Lysates
Cayman Chemical LeukotrIen D4 100ug
An active metabolite of LTC4 and a constituent of SRS-A; induces contractions in isolated guinea pig parenchymal strips and tracheal spirals from 0.01-0.1 pM; increases insufflation pressure in anesthetized guinea pigs by 100% at 89 pmol/animal; intradermal administration increases vascular permeability in guinea pig skin at 0.1 pmol per animal
Cayman Chemical LeukotrIen B4 100ug
A key dihydroxy fatty acid derived from AA through the 5-LO pathway; promotes a number of leukocyte functions including chemotaxis and chemokinesis at subnanomolar concentrations
Cayman Chemical CItrulInATd VImentInhumn 100ug
Source: Human recombinant vimentin purified from E. coli • MW: 53.5 kDa
Reaction Biology Corp BRD4 Full Length protein, human recombinant, 100 μg, N-terminal His-tag, C-terminal StrepII-tag
The REACTION BIOLOGY CORP BRD4 Full Length protein is a human recombinant bromodomain-containing protein 4 that plays a significant role in transcriptional regulation and cell cycle progression. This protein, produced in Sf9 insect cells, features N-terminal His and C-terminal StrepII tags, enabling specific binding to ε-N-acetyllysine residues. Mainly recognized for its function in chromatin regulation, cancer research, and inflammation studies, BRD4 is also an atypical kinase that phosphorylates RNA Polymerase II.
- Produced in Sf9 insect cells
- Active transcriptional regulator
- Contains two bromodomains
- Has a molecular weight of 156.5 kDa
- Tagged with N-terminal His and C-terminal StrepII
- Purity exceeds 85% by SDS-PAGE
- Stored at -70°C or -80°C
- Functionally important for BET bromodomain studies
Cayman Chemical OctopInIc AcId 100ug
An opine; has been found in crown gall tumors induced by the plant pathogenic bacterium A. tumefaciens
Cayman Chemical 15deoxy12 14ProstaglndIn 100ug
An internal standard for the quantification of 15-deoxy-Δ12,14-PGJ2 by GC- or LC-MS
Cell Sciences Inc Research Grade Alnuctamab, Trivalent Bispecific Monoclonal Antibody, 1.0 mg
Research Grade Alnuctamab is a trivalent, bispecific humanized monoclonal antibody designed for laboratory research applications. It uniquely targets human BCMA and CD3e, facilitating T-cell-mediated targeting, making it an advanced reagent for enhanced research results. Provided in a quantity of 1.0 mg, it ensures optimal performance across various research protocols, delivering stability for up to 1 year.
Biolegend PE anti-Syk
PE anti-Syk [4D10.2]; Isotype: Mouse IgG2a, κ; Reactivity: Human; Apps: ICFC; Size: 100 tests